logologo
QuantliQuantli

BioVie Inc

BIVI

NASDAQ

Biotechnology

$1.40

USD

-0.16 (-10.26%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $11.88M

Volume 2.0M

Price (USD)
Price (USD)

About BioVie Inc

The company is headquartered in Carson City, Nevada and currently employs 13 full-time employees. The company went IPO on 2014-01-14.

CEO

Mr. Viet Cuong Do

HQ

Carson City, NEVADA, US

Founded

2014

Employees

13

Key Metrics

2 metrics our research team weighs before forming a view on BIVI.

Based on Quantli research · SEC filings · as of Q4 2026

METRIC

VALUE

CHANGE

TREND (3Y)

ROE (TTM)

-214.9%

-122.7 pp

Free Cash Flow (TTM)

$-19.02M

Financial Snapshot

Full Financials

Revenue

$0

YoY

Gross Margin

YoY

Net Income

$-22.07M

-25.8%

YoY

Operating Cash Flow

$-19.02M

+0.0%

YoY

Key Statistics

Open

$1.42

Previous Close

$1.56

Day Range

$1.25 - $1.51

52 Week Range

$0.82 - $3.79

Volume

2.0M

Average Volume (10 Days)

14.4M

Dividend Yield

Valuation Measurement

Market Cap

$11.88M

P/E Ratio (TTM)

Price / Book

1.16

Financial Highlights

Return on Assets

-154.9%

Return on Equity

-214.9%

Revenue (TTM)

$0

Net Income (TTM)

$-22.07M

Diluted EPS (TTM)

-$3.13

Total Cash (MRQ)

$8.98M

Levered FCF (TTM)

$-19.02M

Turn research into action

Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.

Swing Strategy

Buy support, sell on recovery.

Best for:

Risk-tolerant

Trend Following

Enter on trend. Cut losses fast.

Best for:

Active traders

Position Strategy

Ride market cycles. Patient hold.

Best for:

Patient investors

Go deeper on BIVI

Similar Stocks

XCUR

Exicure Inc

$1.25

-4.6%

VTGN

Vistagen Therapeutics Inc

$0.2700

+0.5%

LNAI

Lunai Bioworks Inc

$2.22

-0.9%

LSTA

Lisata Therapeutics Inc

$1.09

-3.5%

MTVA

MetaVia Inc

$1.49

+2.0%

INAB

IN8bio Inc

$1.10

-6.8%

OSRH

OSR Holdings Inc

$0.3200

+11.7%

LIMN

Liminatus Pharma Inc

$0.1400

-6.6%

IMNN

Imunon Inc

$1.65

+4.4%

Earnings Calendar

Next Earnings

Estimated Q1 Release

Nov 09